• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Research & Development

Astronauts to use diabetes tech in outer space on upcoming mission

May 8, 2025 By Sean Whooley

Ax-4 Axiom space mission diabetes research

A mission to outer space includes plans to utilize modern diabetes management technology to assess its viability in microgravity. The Ax-4 mission, set to launch on May 29, aims to demonstrate that astronauts with insulin-dependent diabetes can be supported over short-duration stays in microgravity. Ax-4 features several areas of research and science-related activities planned for […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Research & Development, Technology Tagged With: International Space Station

Glucotrack to bring implantable CBGM to automated insulin delivery system initiative in Europe

April 16, 2025 By Sean Whooley

GlucoTrack updated Logo (1)

Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe. FORGETDIABETES aims to develop a long-term automated insulin delivery system. This system should enable optimal glucose control without patient intervention. The initiative, funded by the European Union’s Horizon 2020 research and innovation program, offers support from basic research to […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Research & Development Tagged With: Glucotrack

Tandem inks collab with UVA to develop closed-loop automated insulin delivery tech

January 7, 2025 By Sean Whooley

Tandem Diabetes Care updated logo

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it signed a multi-year R&D collaboration agreement with the University of Virginia (UVA). The collaboration with the UVA Center for Diabetes Technology aims to advance R&D efforts on fully automated, closed-loop insulin delivery systems. Tandem develops its own closed-loop systems, including the t:slim X2 and Mobi pumps, which […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Research & Development, Technology Tagged With: Tandem Diabetes Care, universityofvirginia

NIH launches effort to combat type 2 diabetes in young people

October 10, 2024 By Sean Whooley

NIH National Institutes of Health

The National Institutes of Health (NIH) launched a nationwide consortium to address the rise in youth diagnosed with type 2 diabetes. According to a press release, NIH expects that trend — which it observed over the past two decades — to continue moving forward. It aims to advance understanding of the biologic, social, and environmental […]

Filed Under: Clinical Trials, Diabetes, Featured, Pediatrics, Research & Development Tagged With: National Institutes of Health

This simple, needle-free COVID vaccination device might stop transmission

August 7, 2024 By Jim Hammerand

“Finally,” many of us thought when we received our first jabs to vaccinate us against COVID-19 back in 2020 and 2021. Nearly four years later, COVID is still surging, constantly mutating to create new variants that evade our immunity from prior infections and the latest vaccines. And if the immediate and long-term harm from SARS-CoV-2 […]

Filed Under: Pharmaceuticals, Research & Development Tagged With: Bharat Biotech International, Washington University in St. Louis

Phillips-Medisize, GlucoModicum partner on needle-free CGM

October 3, 2023 By Sean Whooley

Phillips-Medisize GlucoModicum Talisman non-invasive CGM

Molex company Phillips-Medisize today announced a partnership with GlucoModicum to design a new continuous glucose monitor (CGM). The companies teamed up to design and eventually commercialize a proprietary, non-invasive, wearable CGM device. They aim to remove the technology and patient-care roadblocks that exist within continuous glucose monitoring. Phillips-Medisize develops drug delivery, in vitro diagnostic and […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Research & Development, Technology Tagged With: GlucoModicum, Phillips-Medisize

This biodegradable brain implant delivers cancer-treating drugs

July 13, 2023 By Sean Whooley

Researchers say they developed a biodegradable brain implant capable of helping to deliver chemotherapy drugs directly to tumors. Medscape News reported that the research marks another step toward using ultrasound to combat cancer. According to the team, led by Thanh Nguyen, these drugs can penetrate the blood-brain barrier to reach these brain tumors. Nguyen serves […]

Filed Under: Drug-Device Combinations, Implants, Oncology, Research & Development, Technology Tagged With: University of Connecticut

Humacyte, JDRF to develop biovascular pancreas to treat type 1 diabetes

April 27, 2023 By Sean Whooley

JDRF Humacyte

Humacyte (Nasdaq:HUMA) and JDRF announced today that they entered into a collaboration to develop a biovascular pancreas (BVP). The collaboration aims to advance the development of Humacyte’s BVP product candidate for treating type 1 diabetes. Humacyte designed its BVP to deliver insulin-producing islets using its investigational, tissue-engineered blood vessel. The company calls it the Human […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Research & Development Tagged With: Humacyte, Juvenile Diabetes Research Foundation (JDRF)

Researchers develop wearable patch for painless drug delivery through the skin

April 21, 2023 By Sean Whooley

MIT Ultrasound Patch for drug delivery

Researchers at MIT hope to address the difficulties of transdermal drug delivery through a new wearable patch. The MIT team sees the skin as an appealing route for drug delivery. It enables the drugs to travel directly to the necessary site, which offers benefits in wound care, pain relief and more. However, the tough outer […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Research & Development, Technology Tagged With: Drug delivery, Massachusetts Institute of Technology, mit, wearables

Researchers use tiny drug delivery implant to treat tumors

April 14, 2023 By Sean Whooley

Houston Methodist Research Institute tiny drug delivery implant

Researchers at Houston Methodist Research Institute developed a tiny drug delivery device for addressing difficult-to-treat cancers. The researchers published their work in a paper in Advanced Science. They used an implantable nanofluidic device they invented to deliver CD40 monoclonal antibodies (mAB). The team calls the device a nanofluidic drug-eluting seed (NDES). With the device  — […]

Filed Under: Drug-Device Combinations, Featured, Implants, Oncology, Research & Development Tagged With: Houston Methodist Research Institute

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 48
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS